# China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese Population

> **NCT03466918** · NA · COMPLETED · sponsor: **Edwards Lifesciences** · enrollment: 58 (actual)

## Conditions studied

- Aortic Stenosis
- Symptomatic Aortic Stenosis
- Aortic Regurgitation

## Interventions

- **DEVICE:** SAPIEN 3 THV with the Commander delivery system

## Key facts

- **NCT ID:** NCT03466918
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-23
- **Primary completion:** 2019-07-03
- **Final completion:** 2024-06-19
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03466918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03466918, "China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese Population". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03466918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*